Skip to main content

Influence of hemolysis on routine clinical chemistry testing.

Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC

Publication: Clin Chem Lab Med (2006) • Vol 44 • Page 311-6PMID: 16519604View on PubMed

Purpose

The purpose of this paper was to determine the effects of hemolysis on the measurement of common clinical chemistry analytes.

Conclusion

Hemolysis interference with the measurement of clinical chemistry analytes was generally linear and affected 17 of 20 analytes. Aspartate amino transferase (AST), chloride, lactate dehydrogenase (LDH), sodium, and potassium levels were the most affected by free serum hemoglobin. Calcium, total bilirubin, and glucose showed no clinically significant changes in specimens containing added levels of free hemoglobin compared to those with no hemolysis.

Studies (1)

Purpose

The purpose of this study was to determine the effects of hemolysis on the measurement of common clinical chemistry analytes. Hemolysis was achieved by subjecting whole blood to an overnight freeze-thaw cycle, mixing it with serum that was also frozen overnight (-70 degrees C), and subsequently using this mixture for serial dilution of fresh blood specimens. Resulting fresh serum specimens contained free hemoglobin levels between 0 and 20.6 g/L.

Summary of Findings

As expected, subjecting whole blood to an overnight freeze-thaw cycle lowered white blood cell, platelet, and erythrocyte counts beyond the analytical sensitivity of the analyzer. Hemolysis interference with the measurement of clinical chemistry analytes was generally linear and led to overestimation of alanine amino transferase (ALT), creatinine, AST, creatine kinase (CK), iron, LDH, magnesium, potassium, lipase, phosphorus, and urea nitrogen and underestimation of albumin, alkaline phosphatase (ALP), chloride, gamma-glutamyltransferase (GGT), sodium, and uric acid. AST, chloride, LDH, sodium, and potassium levels were the most affected by free serum hemoglobin. Calcium, total bilirubin, and glucose showed no clinically significant changes in specimens containing added levels of free hemoglobin compared to those with no hemolysis.

  • Biospecimens

    FluidBlood
    FluidSerum
  • Preservation Types

    None (Fresh)Frozen
  • Diagnoses

    Normal
  • Platforms

    ProteinSpectrophotometry
    ProteinClinical chemistry/auto analyzer
    Small moleculeClinical chemistry/auto analyzer
    Electrolyte/MetalClinical chemistry/auto analyzer
    CarbohydrateClinical chemistry/auto analyzer
    ProteinHematology/ auto analyzer
    Cell count/volumeHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBiospecimen components
    0 g/L serum hemoglobin
    0.16 g/L serum hemoglobin
    0.3 g/L serum hemoglobin
    0.6 g/L serum hemoglobin
    1.3 g/L serum hemoglobin
    10.3 g/L serum hemoglobin
    2.6 g/L serum hemoglobin
    20.6 g/L serum hemoglobin
    5.1 g/L serum hemoglobin
    Biospecimen Aliquots and ComponentsHemolysis
    Freeze/thaw-induced
    Hemolysate added
    No hemolysate added
    Biospecimen PreservationType of fixation/preservation
    Frozen
    None (fresh)